References
Key articles
Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Full text Abstract
Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019 Aug 1;97(8):548-562P.Full text Abstract
Centers for Disease Control and Prevention. Sexually transmitted infections surveillance: national overview of STIs, 2022. Jan 2024 [internet publication].Full text
Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Full text Abstract
US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Full text
Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Full text Abstract
American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Full text
Reference articles
1. Torrone E, Papp J, Weinstock H. Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012. MMWR Morb Mortal Wkly Rep. 2014 Sep 26;63(38):834-8.Full text Abstract
2. Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS. 2016 Mar;27(4):251-67.Full text Abstract
3. Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019 Aug 1;97(8):548-562P.Full text Abstract
4. Centers for Disease Control and Prevention. Sexually transmitted infections surveillance: national overview of STIs, 2022. Jan 2024 [internet publication].Full text
5. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187.Full text Abstract
6. Public Health England. Sexually transmitted infections and screening for chlamydia in England, 2019. Dec 2019 [internet publication].Full text
7. Bachmann NL, Polkinghorne A, Timms P. Chlamydia genomics: providing novel insights into chlamydial biology. Trends Microbiol. 2014 Aug;22(8):464-72. Abstract
8. Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016 Jun;14(6):385-400.Full text Abstract
9. Scidmore MA. Cultivation and laboratory maintenance of Chlamydia trachomatis. Curr Protoc Microbiol. 2005 Jul;Chapter 11:Unit 11A.1. Abstract
10. Mertz KJ, McQuillan GM, Levine WC, et al. A pilot study of the prevalence of chlamydia infection in a national household survey. Sex Transm Dis. 1998 May;25(5):225-8. Abstract
11. U.S. Preventive Services Task Force. Sexually transmitted infections: Behavioral counseling. Aug 2020 [internet publication].Full text
12. National Institute for Health and Care Excellence. Reducing sexually transmitted infections. June 2022 [internet publication].Full text
13. Stamm WE. Chlamydia trachomatis infections: progress and problems. J Infect Dis. 1999 Mar;179(suppl 2):S380-3.Full text Abstract
14. Cecil JA, Howell MR, Tawes JJ, et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. J Infect Dis. 2001 Nov 1;184(9):1216-9. Abstract
15. Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae - 2014. MMWR Recomm Rep. 2014 Mar 14;63(RR-02):1-19.Full text Abstract
16. American Society for Microbiology, American Society for Clinical Laboratory Science and American Society for Clinical Pathology. Five things physicians and patients should question. Choosing Wisely, an initiative of the ABIM Foundation. 2022 [internet publication].Full text
17. Moncada J, Schachter J, Liska S, et al. Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol. 2009 Jun;47(6):1657-62.Full text Abstract
18. Cosentino LA, Campbell T, Jett A, et al. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J Clin Microbiol. 2012 Jun;50(6):2005-8.Full text Abstract
19. Kelly H, Coltart CEM, Pant Pai N, et al. Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections. Sex Transm Infect. 2017 Dec;93(S4):S22-S30.Full text Abstract
20. May L, Ware CE, Jordan JA, et al. A randomized controlled trial comparing the treatment of patients tested for chlamydia and gonorrhea after a rapid polymerase chain reaction test versus standard of care testing. Sex Transm Dis. 2016 May;43(5):290-5. Abstract
21. Unemo M, Bradshaw CS, Hocking JS, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017 Aug;17(8):e235-79. Abstract
22. Van Der Pol B, Taylor SN, Mena L, et al. Evaluation of the performance of a point-of-care test for Chlamydia and Gonorrhea. JAMA Netw Open. 2020 May 1;3(5):e204819.Full text Abstract
23. Hoebe CJ, Rademaker CW, Brouwers EE, et al. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women who attend a public health sexually transmitted disease clinic. Sex Transm Dis. 2006 Aug;33(8):491-5. Abstract
24. Whitlock GG, Gibbons DC, Longford N, et al. Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits. Int J STD AIDS. 2018 Apr;29(5):474-82.Full text Abstract
25. Gaydos CA, Ferrero DV, Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium. Sex Transm Dis. 2008 Nov;35(11 suppl):S45-50. Abstract
26. US Preventive Services Task Force. Final recommendation statement. Chlamydia and gonorrhea: screening. Sept. 2021 [internet publication].Full text
27. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 update. Mar 2018 [internet publication].Full text
28. American Academy of Family Physicians. Summary of recommendations for clinical preventive services. July 2017 [internet publication].Full text
29. World Health Organization. WHO guideline on self-care interventions for health and well-being, 2022 revision. 2022 [internet publication].Full text
30. Public Health England. NCSP: programme overview. Jun 2021 [internet publication].Full text
31. National Institute for Health and Care Excellence. Antenatal care for uncomplicated pregnancies. Feb 2019 [internet publication].Full text
32. Lanjouw E, Ouburg S, de Vries HJ, et al. 2015 European guideline on the management of Chlamydia trachomatis infections. Int J STD AIDS. 2016 Apr;27(5):333-48.Full text Abstract
33. Royal Australian College of General Practitioners. Chapter 6.2 sexually transmissible infections: guidelines for preventive activities in general practice 9th edition. 2018 [internet publication].Full text
34. Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital chlamydia trachomatis Infection. N Engl J Med. 2015 Dec 24;373(26):2512-21.Full text Abstract
35. Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804.Full text Abstract
36. Cluver C, Novikova N, Eriksson DO, et al. Interventions for treating genital Chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev. 2017;(9):CD010485.Full text Abstract
37. Centers for Disease Control and Prevention. Expedited partner therapy in the management of sexually transmitted diseases. 2006 [internet publication].Full text
38. American College of Obstetricians and Gynecologists. Committee opinion no. 737: expedited partner therapy. Jun 2018 [internet publication].Full text
39. Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002 Sep;29(9):497-502. Abstract
40. Páez-Canro C, Alzate JP, González LM, et al. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. Cochrane Database Syst Rev. 2019 Jan 25;1:CD010871.Full text Abstract
41. Centers for Disease Control and Prevention. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydial infection. MMWR Recomm Rep. 2008 Nov 7;57(RR-9):1-83.Full text Abstract
42. World Health Organization. WHO guidelines for the treatment of Chlamydia trachomatis. 2016 [internet publication].Full text
43. Xia Q, Wang T, Xian J, et al. Relation of chlamydia trachomatis infections to ectopic pregnancy: a meta-analysis and systematic review. Medicine (Baltimore). 2020 Jan;99(1):e18489.Full text Abstract
44. Ahmadi MH, Mirsalehian A, Bahador A. Prevalence of genital Chlamydia trachomatis in Iran: a systematic review and meta-analysis. Pathog Glob Health. 2015 Sep;109(6):290-9.Full text Abstract
45. Chen JZ, Gratrix J, Brandley J, et al. Retrospective review of gonococcal and chlamydial cases of epididymitis at 2 Canadian sexually transmitted infection clinics, 2004-2014. Sex Transm Dis. 2017 Jun;44(6):359-61.Full text Abstract
46. Denison HJ, Curtis EM, Clynes MA, et al. The incidence of sexually acquired reactive arthritis: a systematic literature review. Clin Rheumatol. 2016 Nov;35(11):2639-48.Full text Abstract
47. Carter JD, Inman RD. Chlamydia-induced reactive arthritis: hidden in plain sight? Best Pract Res Clin Rheumatol. 2011 Jun;25(3):359-74. Abstract
48. Rich E, Hook EW 3rd, Alarcón GS, et al. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthritis Rheum. 1996 Jul;39(7):1172-7. Abstract
49. Darling EK, McDonald H. A meta-analysis of the efficacy of ocular prophylactic agents used for the prevention of gonococcal and chlamydial ophthalmia neonatorum. J Midwifery Womens Health. 2010 Jul-Aug;55(4):319-27. Abstract
Use of this content is subject to our disclaimer